All Articles

Canon's new AI for CT scanners promises near-photon-counting quality. Is this a true leap forward for diagnostics or a clever stopgap in a competitive market?

A new 185MW solar farm in Arkansas, backed by the LEGO family's fund, reveals how corporate demand and patient capital are reshaping the American energy grid.

As federal deadlines for quantum-proof security loom, a retired Navy admiral joins a tech firm. This isn't just a new job; it's a national security race.

A new partnership brings autonomous AI agents to the lab, promising to slash drug development timelines. But can these 'AI scientists' be trusted with our future medicines?

Dave Inc. promotes Gopi Kuchimanchi to CTO, a strategic move reinforcing its reliance on proprietary AI to navigate a competitive neobank market.

Boston-based Assail launches Sidewinder, an AI that autonomously finds exploits, fixes its own mistakes, and learns. Is this the end of traditional pentesting?

The Vetster-PetSmart Canadian partnership embeds virtual vets into retail, signaling a major shift in pet care delivery and market strategy. What does it mean?

Doona's new X model adds a game-changing recline and other key upgrades, but at $850, it faces stiff competition and questions about its long-term value.

With new President Tera Keatts, the Denver agency bets on deep industry expertise and tech adoption to amplify its niche dominance and redefine client value.

Nanoscope's revolutionary MCO-010 gene therapy offers hope to millions with retinal disease. A new partnership with Catalent is the critical final step.

Associated Capital Group's rising book value isn't just a number. It's a signal of a focused strategy executing in a dynamic alternative investment market.

Precinmac's acquisition of Advance Mfg. is more than a purchase; it's a calculated move to build a one-stop shop for mission-critical components.

A new report shows grocers betting big on tech and health despite razor-thin profits. This isn't just survival; it's a strategic play for future market dominance.

Pediatrica Health's $28M Series B aims to fix a broken system. With investors betting on 'equitable access,' is this the future of child healthcare?

Lumanity's aggressive, science-based emissions targets are not just for the planet—they are a calculated move to win business in the demanding biopharma sector.

A new FICO survey reveals a stark reality: most non-homeowners feel priced out. High prices, rising rates, and financial confusion are sidelining buyers.

An alliance between Ericsson, AT&T, and MediaTek has just fixed one of mobile's biggest flaws, unlocking the true potential of XR, physical AI, and more.

Christina Fisher's appointment is more than a new CFO. It’s a strategic move to steer UL's massive endowment and global safety ambitions. What does it signal?

For millions with the debilitating condition dysautonomia, diagnosis is a long, frustrating journey. A new technology promises to replace subjective guesswork with hard data.